U.S. Senator Ron Wyden, alongside Sens. Rand Paul (R-KY) and Jeff Merkley (D-OR), announced the reintroduction of The Hemp Access and Consumer Safety Act, a bill that would establish a framework for the U.S. Food and Drug Administration (FDA) to regulate hemp-derived CBD as a dietary supplement or food and beverage additive. The U.S. Hemp Roundtable strongly endorses this legislation and applauds Sen. Wyden and his Congressional colleagues for championing efforts to regulate CBD products in the Senate.
"We commend Senator Ron Wyden for reintroducing The Hemp Access and Consumer Safety Act, a crucial piece of legislation that addresses the pressing need for FDA regulation of CBD," said Jonathan Miller, General Counsel of the U.S. Hemp Roundtable. "This bill provides a much-needed pathway for the FDA to establish a clear and consistent framework for the production, marketing, and sale of hemp-derived CBD to ensure consumer safety while fostering a thriving, regulated market. We look forward to supporting his efforts and appreciate his longtime commitment to unlocking the full potential of the hemp industry."
The bill boasts strong and growing hemp industry support. In addition to the U.S. Hemp Roundtable, The Hemp Access and Consumer Safety Act of 2023 is endorsed by national advocacy organizations, including We Are For Better Alternatives (WAFBA), the American Herbal Products Association (AHPA), the Hemp Industries Association (HIA), National Hemp Growers Association, Realm of Caring, U.S. Hemp Authority (USHA) and Veterinary Cannabis Society, along with regional and state-based groups such as the Midwest Hemp Council, Colorado Hemp Association, Kentucky Hemp Association, Georgia Hemp Association, iHemp Michigan, South Dakota Industrial Hemp Association, and the Virginia Hemp Coalition. View Senator Wyden's press release here.
For more information:
U.S. Hemp Roundtable 
www.hempsupporter.com
Sign up for our daily Newsletter and stay up to date with all the latest news!
Subscribe I am already a subscriber